Company Quick10K Filing
Comstock
10-Q 2021-03-31 Filed 2021-05-14
10-K 2020-12-31 Filed 2021-03-31
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-28
10-K 2019-12-31 Filed 2020-04-15
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-20
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-16
10-K 2017-12-31 Filed 2018-04-20
10-Q 2017-09-30 Filed 2017-11-16
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-04
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-13
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-27
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-07-27
10-Q 2012-03-31 Filed 2012-05-11
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-12
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-31
8-K 2020-08-05
8-K 2020-06-24
8-K 2020-06-17
8-K 2020-04-27
8-K 2020-04-20
8-K 2020-03-19
8-K 2019-12-30
8-K 2019-06-19
8-K 2019-04-30
8-K 2019-02-12
8-K 2018-06-12
8-K 2018-06-12
8-K 2018-05-22
8-K 2018-03-30

Comstock Financials

CHCI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3,0896,4885,6397,9137,0114,4423,5399,33511,4114,18811,8957,3634,8144,9277,4985,4306,1522,48812,4484,6133,3772,5565,7613,7022,6192,0861,8062,1996,9624,7177,0116,8931,6031,598
Accounts Receivable2,2281,5991,0661,2981,6111,6801,6751,8813465231,2993351109889545193327901,1025146131447481,3326366345962,4801,3291,434905954
Inventory
PP&E408810595871853632372662504542232022607064434784547663392912828012191943291,0332992622411,120205221244
Assets42,50448,99646,37934,98131,02929,09238,69942,06947,68351,14956,87954,11055,50654,41856,36758,85862,00959,55258,47848,42447,33956,57559,82156,39655,82356,01351,15853,29845,91839,10835,10030,92127,98616,071
Accounts Payable687
Long-Term Debt16,83318,43327,62922,29324,57821,64743,70443,56842,49044,04639,39339,45626,15822,98818,93015,5636,3836,326
Liabilities35,58334,15633,83521,05519,89122,09432,32027,42931,89235,33837,82037,79042,75943,79854,51258,29958,50857,03353,03745,63347,29353,94851,44450,52251,43352,90348,54851,17934,60031,48128,47023,82620,9738,850
Stockholders' Equity4,32112,1209,70313,92611,1386,9715,4446,5075,8025,2004,1652,8071,1341,135-2,131-2,852-2,644-3,644-1,276-2,962-4,838-5,762-9,875-10,453-10,015-11,356-14,376-14,963-5,949-8,203-9,076-8,9117,0137,221
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue8,79914,30014,93911,3584,9225,240
Cost of Revenue8,21314,72315,10210,5334,4234,572
Gross Profit2,5402,2563,2662,3331,5621,7821,4364,4629706401,0332749431,003484113586-423-163825499668
R&D
SG&A1,9331,6812,4441,8862,3012,1832,4931,9972,2152,1962,3022,4272,9382,2262,1852,3222,4252,3512,3882,0251,7761,6631,7281,6271,5761,6641,930579577523419477453
Tax082-49-912-1,202-3644,96203641971497457137100-705736-755-25320-2002996-484-438300
Net Income-1,5586,661-2,7334,054-3,115-4,496-2,0051,0624,3812501,235-843-669991-2,593-668-2741,0912-1,288-1,461-756-3,257-647387-1,201-2,378-628-215-1,614369-253-643
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating8,6501,270-1,09546-4,088-10,9044,079-1,254-8,8111,647-2,591-7134,056-5,976-3,775-1,798-1,7799,912-3851,012-6,849-5,5945261,3851,0632,090-492,7252,8823,494465
Cash Investing-3,280-50818,4000376141248-45-6984-111-98-393862-163-209-219-150-80-3274265-124-16-613-81-371-5-3743
Cash Financing509-1,611-15,031-9481,1439,8601,4693,3751,5945,076-1,830-1,738-3,5507,6851,8702,729-2,393925-7,370-2,2165,8628,626-2,461-2,452-983-2,289-662-4,971-2,995-2,590-513